·Î±×ÀÎ Àüü´º½º¿ÀÇǴϾðEnglishÆÊ ¾ÆÄ«µ¥¹ÌÆÊ½ºÅ¸Å¬·´TVÆÊµµ¶ó¸®Äí¸£Æ®DPºÎµ¿»êÀλ絿Á¤Event & Çмú¼¼¹Ì³ªµ¶ÀÚÁ¦º¸
°Ë»ö ä¿ëÁ¤º¸ 'Åõ¿¢½ººñ' À¯Æ©ºê ±¤°í Á¶È¸ ¼ö 350¸¸ µ¹ÆÄ ±â»çÀÔ·Â : 20.04.27 11:20:10 0 °¡ ÇÃÄ£Ãß°¡ Á¦ÀÏÇコ»çÀ̾𽺠"ÇÇ·ÎÇÑ Çö´ëÀÎ ÄÚ¹ÍÇÏ°Ô Ç¥Çö" AD 11¿ù 4ÁÖÂ÷ ¸ÅÃ⠺м®ÀÌ ÇÊ¿äÇϸé? BRPInsight [µ¥Àϸ®ÆÊ=Á¤ÇýÁø ±âÀÚ] Á¦ÀÏÇコ»çÀ̾𽺴 Ȱ¼ººñŸ¹ÎÁ¦ 'Åõ¿¢½ººñ' À¯Æ©ºê ±¤°í Á¶È¸ ¼ö°¡ 4¿ù ¸» ±âÁØ 350¸¸ºä¸¦ ³Ñ¾î¼¹´Ù°í ¹àÇû´Ù. Åõ¿¢½ººñ´Â Á¦ÀÏÇコ»çÀ̾𽺰¡ ÃÖ±Ù Á¦Ç° ÆÐŰÁö¸¦ ¸®´º¾óÇØ Ãâ½ÃÇÑ °íÇÔ·® Ȱ¼ººñŸ¹ÎÀÌ´Ù. ȸ»ç´Â ÀþÀº ÃþÀ» °Ü³ÉÇØ Áö³ÇØ ¸»ºÎÅÍ À¯Æ©ºê¿¡ 5ÆíÀ¸·Î ±¸¼ºµÈ ±¤°í¸¦ °ÔÀçÇß´Ù. Á¦ÀÏÇコ»çÀ̾𽺠°ü°èÀÚ´Â "º¥Æ÷Ƽ¾Æ¹Î, ¸®º¸Çöóºó, UDCA, ÄÚ¿£ÀÚÀÓÅ¥ÅÙ µî ÃÑ 16°¡Áö À¯È¿¼ººÐÀÇ 1ÀÏ º¹¿ë·®À» ÇÑ ¾Ë¿¡ ´ã¾Ò´Ù"¸ç "Çö´ëÀÎÀÇ ÇÇ·Îȸº¹°ú Ȱ·ÂÁõ´ë¿¡ µµ¿òÀ» ÁÖ´Â Á¦Ç°"À̶ó°í ¼Ò°³Çß´Ù. Á¦ÀÏÇコ»çÀ̾𽺴 À̹ø ±¤°íÄ·ÆäÀÎÀ» ºñ·ÔÇØ ÇâÈÄ ¼ÒºñÀÚ ´ë»ó ¸¶ÄÉÆÃȰµ¿À» °ÈÇÑ´Ù´Â ¹æÄ§ÀÌ´Ù. X AD »çÀüµî·Ï GO À̺¥Æ®Âü¿© ¡æ Á¤ÇýÁø ±âÀÚ(7407057@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç [°æ±âµµ ±¤ÁÖ] º¹»ê³ªÀ̽º °ü¸®¾à»ç ä¿ë ¹Ù·Î°¡±â ¸ÂÃ㿵¾çÁ¦ ¸ÞµðÄÚÄ¡¿¡¼ ÇÁ¸®·£¼(¿Â¶óÀÎ »ó´ã À§ÁÖ) ¾à»ç¸¦ ¸ðÁýÇÕ´Ï´Ù.(¼ö±Ý ¾ß°£/ÁÖ¸» »ó´ã) ¹Ù·Î°¡±â Çâ³²&¾È¼º Á¦Á¶°ü¸® ¾à»ç ä¿ë(½ÅÀÔ¿ì´ë) ¹Ù·Î°¡±â ¹é¾Ï°øÀå QA¾à»ç ä¿ë °æ·Â¹«°ü ¹Ù·Î°¡±â [¸ÓÅ©ÄÚ¸®¾Æ] Regulatory Affairs Specialist ¹Ù·Î°¡±â Á¦¾à ¿µ¾÷ ½ÅÀÔ ¹× °æ·Â ä¿ë(¾Èµ¿) ¹Ù·Î°¡±â °³¹ßº»ºÎ ±âȹ, RA ÆÀÀå±Þ ä¿ë(°æ·Â 10³â¡è) ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æÄ§ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : Åõ¿¢½ººñ À¯Æ©ºê ±¤°í Á¶È¸ ¼ö 350¸¸ µ¹ÆÄ URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ īī¿À½ºÅ丮 īī¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ 'Åõ¿¢½ººñ' À¯Æ©ºê ±¤°í Á¶È¸ ¼ö 350¸¸ µ¹ÆÄ ±â»çÀÔ·Â : 20.04.27 11:20:10 0 °¡ ÇÃÄ£Ãß°¡ Á¦ÀÏÇコ»çÀ̾𽺠"ÇÇ·ÎÇÑ Çö´ëÀÎ ÄÚ¹ÍÇÏ°Ô Ç¥Çö" AD 11¿ù 4ÁÖÂ÷ ¸ÅÃ⠺м®ÀÌ ÇÊ¿äÇϸé? BRPInsight [µ¥Àϸ®ÆÊ=Á¤ÇýÁø ±âÀÚ] Á¦ÀÏÇコ»çÀ̾𽺴 Ȱ¼ººñŸ¹ÎÁ¦ 'Åõ¿¢½ººñ' À¯Æ©ºê ±¤°í Á¶È¸ ¼ö°¡ 4¿ù ¸» ±âÁØ 350¸¸ºä¸¦ ³Ñ¾î¼¹´Ù°í ¹àÇû´Ù. Åõ¿¢½ººñ´Â Á¦ÀÏÇコ»çÀ̾𽺰¡ ÃÖ±Ù Á¦Ç° ÆÐŰÁö¸¦ ¸®´º¾óÇØ Ãâ½ÃÇÑ °íÇÔ·® Ȱ¼ººñŸ¹ÎÀÌ´Ù. ȸ»ç´Â ÀþÀº ÃþÀ» °Ü³ÉÇØ Áö³ÇØ ¸»ºÎÅÍ À¯Æ©ºê¿¡ 5ÆíÀ¸·Î ±¸¼ºµÈ ±¤°í¸¦ °ÔÀçÇß´Ù. Á¦ÀÏÇコ»çÀ̾𽺠°ü°èÀÚ´Â "º¥Æ÷Ƽ¾Æ¹Î, ¸®º¸Çöóºó, UDCA, ÄÚ¿£ÀÚÀÓÅ¥ÅÙ µî ÃÑ 16°¡Áö À¯È¿¼ººÐÀÇ 1ÀÏ º¹¿ë·®À» ÇÑ ¾Ë¿¡ ´ã¾Ò´Ù"¸ç "Çö´ëÀÎÀÇ ÇÇ·Îȸº¹°ú Ȱ·ÂÁõ´ë¿¡ µµ¿òÀ» ÁÖ´Â Á¦Ç°"À̶ó°í ¼Ò°³Çß´Ù. Á¦ÀÏÇコ»çÀ̾𽺴 À̹ø ±¤°íÄ·ÆäÀÎÀ» ºñ·ÔÇØ ÇâÈÄ ¼ÒºñÀÚ ´ë»ó ¸¶ÄÉÆÃȰµ¿À» °ÈÇÑ´Ù´Â ¹æÄ§ÀÌ´Ù. X AD »çÀüµî·Ï GO À̺¥Æ®Âü¿© ¡æ Á¤ÇýÁø ±âÀÚ(7407057@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç [°æ±âµµ ±¤ÁÖ] º¹»ê³ªÀ̽º °ü¸®¾à»ç ä¿ë ¹Ù·Î°¡±â ¸ÂÃ㿵¾çÁ¦ ¸ÞµðÄÚÄ¡¿¡¼ ÇÁ¸®·£¼(¿Â¶óÀÎ »ó´ã À§ÁÖ) ¾à»ç¸¦ ¸ðÁýÇÕ´Ï´Ù.(¼ö±Ý ¾ß°£/ÁÖ¸» »ó´ã) ¹Ù·Î°¡±â Çâ³²&¾È¼º Á¦Á¶°ü¸® ¾à»ç ä¿ë(½ÅÀÔ¿ì´ë) ¹Ù·Î°¡±â ¹é¾Ï°øÀå QA¾à»ç ä¿ë °æ·Â¹«°ü ¹Ù·Î°¡±â [¸ÓÅ©ÄÚ¸®¾Æ] Regulatory Affairs Specialist ¹Ù·Î°¡±â Á¦¾à ¿µ¾÷ ½ÅÀÔ ¹× °æ·Â ä¿ë(¾Èµ¿) ¹Ù·Î°¡±â °³¹ßº»ºÎ ±âȹ, RA ÆÀÀå±Þ ä¿ë(°æ·Â 10³â¡è) ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æÄ§ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : Åõ¿¢½ººñ À¯Æ©ºê ±¤°í Á¶È¸ ¼ö 350¸¸ µ¹ÆÄ URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ īī¿À½ºÅ丮 īī¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ 'Åõ¿¢½ººñ' À¯Æ©ºê ±¤°í Á¶È¸ ¼ö 350¸¸ µ¹ÆÄ ±â»çÀÔ·Â : 20.04.27 11:20:10 0 °¡ ÇÃÄ£Ãß°¡ Á¦ÀÏÇコ»çÀ̾𽺠"ÇÇ·ÎÇÑ Çö´ëÀÎ ÄÚ¹ÍÇÏ°Ô Ç¥Çö" AD 11¿ù 4ÁÖÂ÷ ¸ÅÃ⠺м®ÀÌ ÇÊ¿äÇϸé? BRPInsight [µ¥Àϸ®ÆÊ=Á¤ÇýÁø ±âÀÚ] Á¦ÀÏÇコ»çÀ̾𽺴 Ȱ¼ººñŸ¹ÎÁ¦ 'Åõ¿¢½ººñ' À¯Æ©ºê ±¤°í Á¶È¸ ¼ö°¡ 4¿ù ¸» ±âÁØ 350¸¸ºä¸¦ ³Ñ¾î¼¹´Ù°í ¹àÇû´Ù. Åõ¿¢½ººñ´Â Á¦ÀÏÇコ»çÀ̾𽺰¡ ÃÖ±Ù Á¦Ç° ÆÐŰÁö¸¦ ¸®´º¾óÇØ Ãâ½ÃÇÑ °íÇÔ·® Ȱ¼ººñŸ¹ÎÀÌ´Ù. ȸ»ç´Â ÀþÀº ÃþÀ» °Ü³ÉÇØ Áö³ÇØ ¸»ºÎÅÍ À¯Æ©ºê¿¡ 5ÆíÀ¸·Î ±¸¼ºµÈ ±¤°í¸¦ °ÔÀçÇß´Ù. Á¦ÀÏÇコ»çÀ̾𽺠°ü°èÀÚ´Â "º¥Æ÷Ƽ¾Æ¹Î, ¸®º¸Çöóºó, UDCA, ÄÚ¿£ÀÚÀÓÅ¥ÅÙ µî ÃÑ 16°¡Áö À¯È¿¼ººÐÀÇ 1ÀÏ º¹¿ë·®À» ÇÑ ¾Ë¿¡ ´ã¾Ò´Ù"¸ç "Çö´ëÀÎÀÇ ÇÇ·Îȸº¹°ú Ȱ·ÂÁõ´ë¿¡ µµ¿òÀ» ÁÖ´Â Á¦Ç°"À̶ó°í ¼Ò°³Çß´Ù. Á¦ÀÏÇコ»çÀ̾𽺴 À̹ø ±¤°íÄ·ÆäÀÎÀ» ºñ·ÔÇØ ÇâÈÄ ¼ÒºñÀÚ ´ë»ó ¸¶ÄÉÆÃȰµ¿À» °ÈÇÑ´Ù´Â ¹æÄ§ÀÌ´Ù. X AD »çÀüµî·Ï GO À̺¥Æ®Âü¿© ¡æ Á¤ÇýÁø ±âÀÚ(7407057@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç
0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æÄ§ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : Åõ¿¢½ººñ À¯Æ©ºê ±¤°í Á¶È¸ ¼ö 350¸¸ µ¹ÆÄ URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ īī¿À½ºÅ丮 īī¿ÀÅå ¹êµå ³×À̹ö